Novavax Inc. Stock Rallies 10.2%, Outperforms Peers
Dow Jones2026/11/06 21:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. surged 10.2% to $10.78 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 24,579.42 and the Dow Jones Industrial Average falling 0.5% to 51,285.73.
Novavax Inc. closed 19.5% below its 52-week high of $13.39, which the company reached on October 5th.
The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $276.22, Pfizer Inc. fell 0.2% to $29.39, and Merck & Co. Inc. fell 0.14% to $146.73.
Trading volume totaled 6.3 million, compared to the 50-day average of 6.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 06, 2026 16:33 ET (21:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Client nodes, console, and API were not modified; Chainstack discloses attacker used the ARTEX framework

Elon Musk changes his stance! Tesla (TSLA.US) delays Cybertruck production halt to late summer 2027, just two days after suggesting “refund deposits”
Elon Musk stated that Cybertruck production will be extended until late summer 2027 to clear the order backlog, and Tesla's stock price rose by about 4%.
